Skip to main content
CivicGate

← Organizations

Akin Gump Strauss Hauer & Feld

lobbying firm

Akin Gump Strauss Hauer & Feld's federal footprint as a lobbying firm — reported lobbying it billed or handled on behalf of the clients it represents (this is the firm's reported revenue for that work, not its own spending). Figures are as reported to the U.S. Senate (LDA).

Lobbying from Senate LDA

Reported lobbying billed / handled $232,840,000
Firm activeFY2022–FY2026

Reported country: 🇺🇸 United States

Lobbying over time

Reported lobbying for Akin Gump Strauss Hauer & Feld per filing year
FYLobbying billed / handled (as firm)
2022$54,590,000
2023$55,570,000
2024$57,020,000
2025$65,590,000
2026$70,000

Reported lobbying revenue for the clients Akin Gump Strauss Hauer & Feld represents — not the firm's own spending.

Clients represented

  • Gila River Indian Community $11,360,000 · 16 filings
  • Partnership To Address Global Emissions, INC. $7,380,000 · 14 filings
  • Nippon Steel Corporation $7,290,000 · 9 filings
  • Qualcomm Incorporated $3,650,000 · 16 filings
  • Argentem Creek Partners Lp $3,640,000 · 16 filings
  • Zte Corporation $3,430,000 · 16 filings
  • Southeastern Conference $2,830,000 · 16 filings
  • Pharmaceutical Research And Manufacturers Of America $2,370,000 · 16 filings
  • Business Roundtable $2,280,000 · 17 filings
  • Associations Of Mexican Tomato Growers $2,060,000 · 15 filings

Clients Akin Gump Strauss Hauer & Feld filed lobbying for, by reported amount billed/handled.

Issues

Issue area Worked
Taxation/Internal Revenue Code 969
Trade (domestic/foreign) 609
Health Issues 510
Transportation 269
Budget/Appropriations 221
Consumer Issues/Safety/Products 216
Manufacturing 197
Medicare/Medicaid 191
Energy/Nuclear 187
Defense 164
Agriculture 160
Government Issues 158
Telecommunications 141
Banking 122
Financial Institutions/Investments/Securities 120
Copyright/Patent/Trademark 112
Environment/Superfund 110
Labor Issues/Antitrust/Workplace 106
Foreign Relations 104
Science/Technology 104
Indian/Native American Affairs 97
Economics/Economic Development 88
Aviation/Airlines/Airports 77
Immigration 70
Veterans 70
Education 68
Apparel/Clothing Industry/Textiles 54
Computer Industry 52
Communications/Broadcasting/Radio/TV 49
Housing 49

Issue areas across Akin Gump Strauss Hauer & Feld's filings, by activity count. Linked areas open the CivicGate issue page.

What they lobbied on

Reported activity from Senate LDA

  • FY2026 Agriculture

    Issues related to Farm Bill provisions; Issues related to Environmental Protection Agency (EPA) registration and labeling of pesticide applications.

  • FY2026 Environment/Superfund

    Issues related to Farm Bill provisions; Issues related to Environmental Protection Agency (EPA) registration and labeling of pesticide applications.

  • FY2025 Taxation/Internal Revenue Code

    Issues related to international and energy tax; Issues related to corporate taxation and strategic and policy advice on the fiscal outlook.

  • FY2025 Trade (domestic/foreign)

    Issues related to de minimis rules.

  • FY2025 Health Issues

    Issues related to OTC Drug Monograph User Fee Program reauthorization and non-prescription drug status - The Over-the-Counter Monograph Drug User Fee Amendments (H.R. 4273/S. 2292); Issues related to S. 2529 - A bill to increase the clarity and predictability of the process for developing applications for Rx-to-nonprescription switches; Issues related to the Continuing Appropriations and Extensions Act, 2026 (H.R. 5371).

    H.R. 4273 S. 2292 S. 2529 H.R. 5371

  • FY2025 Trade (domestic/foreign)

    Issues related to supply chains and trade.

  • FY2025 Labor Issues/Antitrust/Workplace

    Issues related to policy matters impacting independent workers, consumers, and businesses.

  • FY2025 Transportation

    Issues related to automated vehicle legislation.

Show 52 more activities

  • FY2025 Government Issues

    Issues related to Executive Orders and their impact on Government contracts.

  • FY2025 Health Issues

    Issues relating to drug pricing proposals including implementation of the Inflation Reduction Act (P.L. 117-169); Rx oversight issues; PBM oversight issues; Issues related to budget reconciliation; Issues related to Most Favored Nation proposals; Issues related to the FTC.

  • FY2025 Trade (domestic/foreign)

    Issues related to IP protection; Market access issues related to PhRMA 232.

  • FY2025 Copyright/Patent/Trademark

    Issues related to patent reform legislation; H.R. 3160/S. 1553 - PREVAIL Act

    H.R. 3160 S. 1553

  • FY2025 Trade (domestic/foreign)

    Issues related to Sec. 232 tariffs on steel and aluminum.

  • FY2025 Manufacturing

    Issues related to Sec. 232 tariffs on steel and aluminum.

  • FY2025 Banking

    Issues related to credit scores.

  • FY2025 Labor Issues/Antitrust/Workplace

    Issues related to antitrust matters related to credit scores.

  • FY2025 Urban Development/Municipalities

    Issues related to infrastructure development; Issues related to grant funding and Fiscal Year 2026 appropriations.

  • FY2025 Transportation

    Issues related to infrastructure development; Issues related to grant funding and Fiscal Year 2026 appropriations.

  • FY2025 Budget/Appropriations

    Issues related to infrastructure development; Issues related to grant funding and Fiscal Year 2026 appropriations.

  • FY2025 Economics/Economic Development

    Issues related to infrastructure development; Issues related to grant funding and Fiscal Year 2026 appropriations.

  • FY2025 Agriculture

    Issues related to United States Department of Agriculture renewable energy programs.

  • FY2025 Tobacco

    Issues related to compliance and enforcement to address and prohibit the importation and sale of illicit flavored, disposable electronic nicotine delivery system (ENDS) products; Issues related to tobacco harm reduction efforts.

  • FY2025 Health Issues

    Issues related to tobacco harm reduction efforts.

  • FY2025 Health Issues

    Support for the use of real time data when making residency position awards and awarding new residency/GME slots; Issues related to real time data information in graduate medical education.

  • FY2025 Energy/Nuclear

    Issues related to uranium enrichment.

  • FY2025 Education

    Issues related to the higher education system.

  • FY2025 Consumer Issues/Safety/Products

    Issues related to predatory and deceptive practices in the ticketing market, including H.R. 1402/S. 281 - TICKET Act, and H.R. 2713/S. 196 - MAIN Event Ticketing Act.

    H.R. 1402 S. 281 H.R. 2713 S. 196

  • FY2025 Copyright/Patent/Trademark

    Issues related to music licensing.

  • FY2025 Economics/Economic Development

    Issues related to H.R. 617/S. 195 - American Music Tourism Act of 2025.

    H.R. 617 S. 195

  • FY2025 Taxation/Internal Revenue Code

    Issues related to tax reform; Issues related to Opportunity Zone incentives.

  • FY2025 Trade (domestic/foreign)

    Issues related to international trade, non-tariff barriers, environmental standards, and reciprocal tariffs.

  • FY2025 Trade (domestic/foreign)

    Issues related to foreign relations and trade; Issues related to U.S. investment.

  • FY2025 Computer Industry

    Issues related to data centers and power demand.

  • FY2025 Energy/Nuclear

    Issues related to data center and power demand.

  • FY2025 Trade (domestic/foreign)

    Issues related to trade and tariffs.

  • FY2025 Aviation/Airlines/Airports

    Issues related to the aviation industry.

  • FY2025 Financial Institutions/Investments/Securities

    Issues related to credit card interchange fees.

  • FY2025 Environment/Superfund

    Communications regarding fluoropolymers in the context of proposed PFAS legislation and regulation.

  • FY2025 Defense

    Issues related to Department of Defense and Department of Homeland Security policies and funding.

  • FY2025 Homeland Security

    Issues related to Department of Defense and Department of Homeland Security policies and funding.

  • FY2025 Energy/Nuclear

    Issues related to Inflation Reduction Act tax credit implementation (P.L. 117-169); Issues related to enhanced geothermal.

  • FY2025 Taxation/Internal Revenue Code

    Issues related to Inflation Reduction Act tax credit implementation (P.L. 117-169).

  • FY2025 Energy/Nuclear

    Issues related to permitting and incentives for manufacturing energy equipment and infrastructure.

  • FY2025 Manufacturing

    Issues related to permitting and incentives for manufacturing energy equipment and infrastructure.

  • FY2025 Taxation/Internal Revenue Code

    Issues related to energy equipment manufacturing incentives.

  • FY2025 Marine/Maritime/Boating/Fisheries

    Issues related to vessel industrial base and incentives.

  • FY2025 Taxation/Internal Revenue Code

    Issues related to corporate taxation; Issues related to the implementation of the One Big Beautiful Bill Act (P.L.119-21); Issues related to expiring tax provisions.

  • FY2025 Banking

    Issues related to credit scores.

  • FY2025 Labor Issues/Antitrust/Workplace

    Issues related to antitrust matters related to credit scores.

  • FY2025 Trade (domestic/foreign)

    Issues related to tariffs.

  • FY2025 Trade (domestic/foreign)

    Issues related to market access in South Korea.

  • FY2025 Health Issues

    Issues related to drug pricing proposals; Issues related to Rx oversight; Issues related to PBM oversight; Issues related to budget reconciliation; Issues related to Most Favored Nation proposals.

  • FY2025 Trade (domestic/foreign)

    Issues related to IP protection; Issues related to market access; Issues related to PhRMA 232.

  • FY2025 Copyright/Patent/Trademark

    Issues related to patent reform legislation; Issues related to H.R. 3160/S. 1553 - PREVAIL Act.

    H.R. 3160 S. 1553

  • FY2025 Government Issues

    Issues related to Tribal 8(a) companies.

  • FY2025 Indian/Native American Affairs

    Issues related to general tribal government; Land-in-trust issues; Tribal 8(a) companies.

  • FY2025 Trade (domestic/foreign)

    Issues related to trade.

  • FY2025 Government Issues

    Issues related to the nomination of Howard Brodie to be the U.S. Ambassador to the Republic of Finland.

  • FY2025 Copyright/Patent/Trademark

    Issues related to patent enforcement; Issues related to H.R. 3160/S. 1553 - PREVAIL Act; Issues related to H.R. 3152/S. 1546 - Patent Eligibility Restoration Act of 2025; Issues related to H.R. 1574/S. 708 - RESTORE Patent Rights Act of 2025.

    H.R. 3160 S. 1553 H.R. 3152 S. 1546 H.R. 1574 S. 708

  • FY2025 Health Issues

    Issues related to behavioral health services, prescription drug monitoring programs, care coordination (including Medicare and Medicaid), and veteran mental health; 988 Suicide and Crisis Lifeline; Issues related to FY26 appropriations bills for Labor-HHS, CJS, Mil-Con-VA; Issues related to H.R. 2483/S. 2121 - SUPPORT for Patients and Communities Reauthorization Act of 2025.

    H.R. 2483 S. 2121

The specific issues and bills Akin Gump Strauss Hauer & Feld reported lobbying on, newest first. Bill references that CivicGate tracks link to the bill; others are shown as reported.